|

MK-8748 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EYE201, Tiespectus

Pipeline

Phase 3: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1

Indications

  • Macular Edema1
  • Diabetic Retinopathy1
  • Diabetes1

Glendale, California1 trial

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Global Research Management ( Site 0066)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.